Clinical Trial

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this study is to document an optimized pharmacologic treatment for patients with Takotsubo Syndrome. There is currently no published documentation in a large number of patients. The study is a Randomized Registry Clinical Trial and in total 1000 patients registered in SWEDEHEART will be included.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-12-07; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2021-03-12
Trial Details
NCT Number NCT04666454
Lead Sponsor Vastra Gotaland Region
Collaborators: Göteborg University
Conditions Takotsubo Syndrome
Enrollment 1,000 participants
Start Date 2020-12-14
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-02